Mometasone Furoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

97 API Suppliers, 36 USDMF, 28 CEP/COS, 9 JDMF, 19 EU WC, 9 KDMF, 31 NDC API, 50 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

93 Drugs in Development

93 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

371 FDF Dossiers, 41 FDA Orange Book, 183 Europe, 21 Canada, 59 Australia, 29 South Africa, 38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1%, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.05MG/INH, AEROSOL, METERED;INHALATION - 0.10MG/INH, AEROSOL, METERED;INHALATION - 0.20MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 0.11MG/INH, POWDER;INHALATION - 0.22MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 1 SPI Pharma, 5 DKSH, 2 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 4 BASF, 1 CD Formulation, 3 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 5 Kerry, 2 Keval Exports, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 9 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Solubilizers, 20 Thickeners and Stabilizers, 17 Parenteral, 16 Fillers, Diluents & Binders, 16 Direct Compression, 11 Topical, 9 Coating Systems & Additives, 9 Film Formers & Plasticizers, 9 Granulation, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 5 Emulsifying Agents, 4 Taste Masking, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents, 3 Controlled & Modified Release, 2 Lubricants & Glidants, 2 Coloring Agents, 1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 49 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 57 Regulatory FDF Prices, 16 Annual Reports

MARKET PLACE

17 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

23 US Patents, 1 US Exclusivities, 34 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19796 / DOSAGE - LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Mometasone Furoate(UNII: 04201GDN4R) (Mometasone - UNII:8HR4QJ6DW8)	Mometasone Furoate	1mg in 1

Inactive Ingredients

Ingredient Name	Merck Sharp & Dohme Corp.
HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)
isopropyl alcohol(ND2M416302)
phosphoric acid(E4GA8884NN)
propylene glycol(6DC9Q167V3)
sodium phosphate, monobasic, monohydrate(593YOG76RN)
water(059QF0KO0R)

Setid 64bd8ed7 1cc2 4cdd 94bc 9f646a88a6f0 Applno 19796 Form Lotion Topical Dosage 0 1 - Drug Product Composition: Mometasone Furoate